Siemens Healthineers AG (OTCMKTS:SMMNY) Given Average Rating of “Buy” by Analysts

Siemens Healthineers AG (OTCMKTS:SMMNY) has been given an average recommendation of “Buy” by the seven research firms that are currently covering the firm, MarketBeat.com reports. Two research analysts have rated the stock with a hold recommendation, two have assigned a buy recommendation and three have assigned a strong buy recommendation to the company.

A number of brokerages have recently issued reports on SMMNY. Zacks Research upgraded shares of Siemens Healthineers from a “strong sell” rating to a “hold” rating in a report on Monday, January 12th. Deutsche Bank Aktiengesellschaft downgraded Siemens Healthineers from a “buy” rating to a “hold” rating in a research note on Thursday, December 4th. Royal Bank Of Canada initiated coverage on Siemens Healthineers in a research note on Wednesday, December 17th. They issued a “moderate buy” rating for the company. Sanford C. Bernstein raised Siemens Healthineers to a “strong-buy” rating in a research report on Tuesday, January 13th. Finally, Citigroup reiterated a “buy” rating on shares of Siemens Healthineers in a report on Friday, January 23rd.

Siemens Healthineers Trading Down 0.6%

Shares of SMMNY opened at $24.12 on Wednesday. The business’s fifty day moving average is $25.88 and its 200 day moving average is $26.60. Siemens Healthineers has a 12-month low of $23.28 and a 12-month high of $30.19.

About Siemens Healthineers

Siemens Healthineers AG is a leading global medical technology company that develops, manufactures and distributes a broad range of products and services for the healthcare sector. Headquartered in Erlangen, Germany, the company focuses on diagnostic and therapeutic imaging, in vitro diagnostics and advanced digital health solutions. As a spin-off from Siemens AG, Siemens Healthineers has leveraged decades of engineering expertise to establish a comprehensive portfolio that addresses critical needs in modern healthcare.

The company’s core offerings include magnetic resonance imaging (MRI), computed tomography (CT), X-ray and molecular imaging systems, as well as laboratory diagnostics equipment and point-of-care testing devices.